Electrical Impedance Tomography for Pediatric ARDS
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to perform a PEEP titration protocol and use EIT to identify the optimal PEEP at which lung overdistention and collapse are most effectively balanced. The primary and secondary aims of the study are as follows: Identify the difference between the optimal PEEP recommended by EIT metrics and the current guideline recommended approach to identifying optimal PEEP in PARDS. There will be a statistically significant difference in the recommended optimal PEEP identified using the EIT PEEP titration tool and that of the PEEP/FiO2 grid recommendations. Determine the difference in physiologic metrics between EIT optimal PEEP and the PEEP/FiO2 recommended PEEP. Participants will undergoing EIT monitoring while being subjected to PEEP titration protocol.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Electrical Impedance Tomography for Pediatric ARDS?
Research shows that Electrical Impedance Tomography (EIT) helps guide mechanical ventilation in children with acute respiratory distress syndrome by optimizing lung recruitment and minimizing overdistension. EIT provides real-time imaging of lung function, which can improve patient outcomes by allowing personalized adjustments to ventilator settings.12345
Is Electrical Impedance Tomography (EIT) safe for use in children?
EIT is generally safe for use in children, with studies showing it is well tolerated and only minor skin irritations like temporary redness occurring in about 10% of patients. No moderate or severe adverse events were reported in studies involving prolonged monitoring in neonates and young children.678910
How is Electrical Impedance Tomography different from other treatments for pediatric ARDS?
Electrical Impedance Tomography (EIT) is unique because it provides real-time, bedside imaging of lung function without using radiation, allowing doctors to monitor and adjust ventilation settings to improve lung function in children with ARDS. This noninvasive technique helps optimize breathing support by showing how air is distributed in the lungs, which is not possible with other standard treatments.123611
Research Team
Anoopindar Bhalla, MD
Principal Investigator
Children's Hospital Los Angeles
Eligibility Criteria
This trial is for children under 18 years old who are on mechanical ventilation and not breathing on their own, meeting the criteria for Pediatric Acute Respiratory Distress Syndrome (PARDS).Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo PEEP titration protocol with EIT monitoring to identify optimal PEEP levels
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Electrical Impedance Tomography (Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Los Angeles
Lead Sponsor
Paul S. Viviano
Children's Hospital Los Angeles
Chief Executive Officer since 2015
Master of Public Health from UCLA Fielding School of Public Health
Alan S. Wayne
Children's Hospital Los Angeles
Chief Medical Officer since 2023
MD